The hemodynamic effects of a new,/3 agonist, prenalterol, were studied in 13 patients with severe left ventricular failure (New York Heart Association functional class III or IV). Seven patients had ischemic heart disease and six congestive cardiomyopathy. Left ventricular function was studied by catheter-tip manometer measurements of left ventricular pressure and simultaneous pressure-volume analysis. To minimize rate-related changes in left ventricular function, studies were performed during constant atrial pacing at 100 beats/min unless the intrinsic heart rate was higher. A 12-mg i.v. dose of prenalterol was infused. The maximum rate of pressure development (peak positive dP/dt) increased from 1084 + 95 mm Hg/sec (mean + SEM) to 1493 ± 176 mm Hg/sec (p < 0.005). Stroke volume and ejection fraction also increased. Left ventricular relaxation, measured as the maximum rate of pressure fall (peak negative dP/dt) improved from -1011 ± 91 to -1202 + 119 mm Hg/sec. Alteration in the time constant of pressure fall (T) also suggested improved relaxation, as it decreased from 71.8 ± 7.7 to 48.5 ± 6.3 msec. Prenalterol also decreased left ventricular stiffness, particularly in patients with very stiff ventricles. As a positive inotropic agent, prenalterol increased left ventricular mean power from 5.2 ± 0.4 to 6.8 ± 0.7 W and left ventricular stroke work from 8.3 + 0.7 to 10.2 ± 1.0 W-sec (p < 0.005). Left ventricular stress did not change significantly. The ratio of the diastolic pressure-time index to the systolic pressure-time index increased significantly (0.53 ± 0.04 and 0.63 ± 0.04, respectively, p < 0.005). Despite different absolute values, the percent changes of left ventricular function were similar in both groups. We conclude that even in patients with severe left ventricular failure, ventricular systolic and diastolic function can be improved by prenalterol. As a result of improved contractility, relaxation and stiffness, left ventricular filling pressure decreased. The data indicate a favorable effect on the balance between myocardial oxygen supply and demand. Intravenous prenalterol is a promising new drug for patients with severe heart failure.
PRENALTEROL, the levo-isomer of S-(-)-l-(4 hydroxyphenoxy)-3-isopropyl-amino-propanol-2 hydrochloride, is a new selective /Th adrenoceptor agonist with little chronotropic effect demonstrable in animal studies.1 When administered orally or intravenously, prenalterol enhanced left ventricular contractility in humans.3 Dose-dependent shortening of electromechanical systole and preejection time have been reported.3 '4 In patients who had suffered acute myocardial infarction, prenalterol increased left ventricular contractility without altering diastolic blood pressure and with little change in heart rate or pulse pressure. 5.6 Left ventricular function improved in patients with severe heart failure.7'-We studied the effects of prenalterol on left ventricular contractility and relaxation, power, wall stress and compliance in patients with marked symptomatic impairment (New York Heart Association [NYHA] functional class III or IV) and either ischemic heart disease (IHD) or congestive cardiomyopathy (COCM).
Methods

Patients
The study was performed in 13 patients (table 1) with severe cardiac failure (NYHA class III or IV). All patients gave informed consent. Their mean age was 52 ± 2.5 years (±+ SEM). All patients had cineangiocardiographically determined ejection fraction below 35%. Seven patients had IHD and six had congestive cardiomyopathy (COCM). All patients were in sinus rhythm and on regular treatment with cardiac glycosides and diuretics. No patient had angina pectoris. Tablet ingestion was stopped 12 hours before cardiac catheterization, which was undertaken without premedication and with patients fasting.
Catheterization, Measurements and Calculations
The left ventricle was catheterized retrogradely through percutaneous puncture of the right femoral artery. The aorta was catheterized through the left femoral artery. Left ventricular pressure was recorded by a micromanometer-tip catheter (Millar Instruments) and aortic pressure by a fluid-filled catheter using a Statham P23 ID transducer. Pulmonary arterial pressure was recorded by a Swan-Ganz catheter using a percutaneous femoral vein technique. Cardiac output was measured by thermodilution on an Edwards 95 1A. The average value of three successive determinations was calculated.
The high-fidelity left ventricular pressure signals VOL 66, No 2, AUGUST 1982 were analyzed at a sampling rate of 400 Hz to yield the following indexes of left ventricular performance, as previously described'0' ": peak systolic and end-diastolic pressure, peak positive dP/dt and the rate of pressure development at a developed pressure of 40 mm Hg over the end-diastolic pressure (dP/dt/DP40). Both of these differentiated values reflect left ventricular contractility, with little afterload dependence and only moderate sensitivity to large increases in preload."2 The two indexes of left ventricular relaxation, peak negative dP/dt and the time constant (T) of the pressure fall from peak negative dP/dt to the early diastolic pressure point, were calculated as described. 1 '-11 In the 30°right anterior oblique projection, 35-mm cineangiocardiograms of the left ventricle were exposed at 50 frames/sec; contrast medium, 0.5 ml/kg, was injected at a rate of 12 ml/sec. The ECG and the left ventricular pressure as well as a cinechronocard were simultaneously recorded at a paper speed of 100 mm/sec. Left ventricular volumes were determined using Simpson's rule without correction by regression analysis.
The single-plane frame-by-frame analysis of the cineangiocardiograms was performed by projecting the cinefilms onto a video screen and outlining the ventricular contour on the screen by hand with a light pen. The digitized information was then transmitted to the computer. The first well-opacified sinus beat, excluding any postextrasystolic beat, was used for measurements. The cineangiocardiograms were calibrated after the catheterization procedure with unchanged x-ray tube and intensifer position by filming a metal ball of known volume in the same position as the patient's heart. The volume analysis was automatically correlated with the instantaneous pressure values by a synchronization signal to both the cineangiocardio-gram and the pressure recordings. Maximal wall stress was calculated according to the method of Sandler and Dodge. 16 From the simultaneous analysis of the left ventricular pressure (P) and volume change (dV/dt), the computer continuously calculated left ventricular power (in watts) as P x dV/dt. Left ventricular systolic work, which is power x dt (in W-sec), was calculated from the area under the systolic power curve, which in turn is equivalent to the area under the pressure-volume diagram. 17
To calculate left ventricular compliance, the diastolic part of the pressure-volume curve was expanded. The plot of pressure vs volume from the early diastolic to the end-diastolic point was almost perfectly exponential. The standard method for verifying exponentiality is the linearity of the semilogarithmic plot of the data, with the correlation coefficient giving a quantitative expression of the linearity. There are difficulties in taking logarithms of pressure values because logarithms can only be taken from dimensionless numbers. A solution to this problem has been proposed.'8 As an index of changes in volume compliance, the slope of the regression ln P/Po = av x V + bv was used. [19] [20] [21] The determination of muscle stiffness is difficult because of practical problems in estimating Lagrangian strain for stress-strain analysis. Therefore, the slope of the logarithmic stress (cr) -circumference (1) regression was used22 23: ln a/cO = am x 1 + bm. Potential subendocardial perfusion was estimated by the ratio of diastolic pressure-time index to systolic pressure-time index (DPTI/SPTI). 24 25 Prenalterol Administration All measurements were performed before (control) and after infusion of 12 mg of prenalterol (Astra Chemicals), given over 35 minutes. Cardiac output 362 CIRCULATION and left ventricular and pulmonary arterial pressures were monitored for 20 minutes after the infusion to verify that a steady state had been achieved. Fifty-five minutes after control measurements, all recordings were repeated. Possible transient changes of left ventricular performance induced by contrast material were thus excluded.20 Atrial pacing at a constant rate of 100 beats/min was performed during control and prenalterol measurements to eliminate influences of changes of heart rate on left ventricular contractility and relaxation unless intrinsic heart rate exceeded this. The t test for paired and unpaired data was used. Similar results were obtained with the Wilcoxon rank test. A p value < 0.05 was considered significant. Values are mean ± SD.
Results (table 2)
After infusion of prenalterol, the patients felt less dyspneic. One patient with a history of ventricular ectopic beats and ventricular tachycardia had fewer ectopic beats. No patients developed excessive tachycardia or angina pectoris. One patient had to be withdrawn from the study because single and couplets of ventricular ectopic beats developed. No other side effects were apparent. In patients with IHD, mean resting heart rate increased from 83.1 ± 7.2 beats/min to 98.3 + 5.9 beats/min (p < 0.001) and in patients with COCM from 82.3 ± 8.0 to 85.3 + 4.8 beats/min (NS). The heart rate was maintained by atrial pacing at 100 beats/min in all patients with COCM. One patient with IHD had a heart rate of 107 beats/min before and 103 beats/min after prenalterol; and after prenalterol, heart rates of 100, 106, 106, and 1 14 beats/min were recorded in other patients who did not need pacing. Thus, in IHD patients, the mean heart rate was 101 + 2.7 beats/min before prenalterol and 104.1 ± 5. 1 beats/min after prenalterol. In patients with IHD, peak positive dP/dt was normal during control periods, whereas in patients with COCM it was significantly depressed (p < 0.005). Prenalterol enhanced left ventricular contractility, as indicated by an increase of peak positive dP/dt and dP/ dt/DP40. Absolute and percent changes for both measurements were more pronounced in patients with IHD than with COCM.
Typical left ventricular end-diastolic and end-systolic silhouettes before and after prenalterol are illustrated in figure 1. Mean end-diastolic and end-systolic volumes decreased after prenalterol. However, in one patient with IHD and three patients with COCM, enddiastolic volume increased slightly. Prenalterol induced a significant increase in stroke volume index and ejection fraction. Ejection fraction increased 25% in both groups ( fig. 2 ).
Indexes of relaxation, which were below normal before prenalterol, improved significantly after prenalterol. Despite lower control values and comparable changes of peak negative dP/dt, T was shortened to a greater degree in COCM (39%) than in IHD (25%).
Left ventricular and myocardial compliance could be analyzed from the continuous pressure-volume and stress-circumference plots in 11 of 13 patients during control recordings and after prenalterol. The effective linearity of the logarithmic pressure-volume regressions before and after prenalterol were confirmed by mean correlation coefficients of 0.913 + 0.021 and 0.889 ± and 0.027. The slope of the relationship between log pressure vs volume decreased significantly (-10.3 x 10-3 ml-1). Log stress vs circumference regressions showed almost perfect linearity, but with a lower correlation coefficient comparable to log pressure vs volume (0.777 + 0.068 and 0.808 + 0.068, respectively). Consideration of data from individual patients revealed that in those with very steep slopes, a consistent decrease occurred in both relations.
The pressure-volume diagrams of the patients with IHD and COCM are shown in figures 3 and 4. Baseline values for left ventricular power and work were below normal, but they increased significantly after prenalterol. The percent changes for patients with IHD were greater than those for patients with COCM. Left ventricular wall stress was diminished in both groups, but more so in IHD than in COCM (NS).
DPTI/SPTI increased significantly after prenalterol. An example is shown in figure 5 . The increase in the area between the aortic and ventricular pressure wave forms during diastole is indicative of increased myocardial perfusion, particularly in the subendocardial zone.
Discussion
Digitalis glycosides and diuretics are used worldwide for treatment of cardiac failure. Vasodilators have opened up new therapeutic possibilities. In severe heart failure, sympathomimetic amines have been used and both dopamine and dobutamine have been shown to have significant inotropic actions. The combination of vasodilators and sympathomimetic amines can be of particular value in the treatment of severe cardiac failure,2628 and the inotropic support provided by dopamine and dobutamine seems greater than that of cardiac glycosides when used in combination with diuretics and vasodilators.29' 30 As patients with severe cardiac failure can be helped acutely by inotropic drugs, long-term treatment has been contemplated and work has therefore proceeded on developing orally administered sympathomimetic amines. 1, 3 Our group of patients showed severe left ventricular dysfunction with symptomatic status of NYHA class III-IV. Left ventricular contractility was diminished.21' 22, 36, 37 Patients with COCM had lower values of dP/dt and dP/dt/DP40 than patients with IHD.
Prenalterol significantly increased left ventricular contractility, as indicated by the improved dP/dt and dP/dt/DP40. These changes were probably not a result of changes in heart rate, because all patients were paced unless the intrinsic heart rate exceeded the pacing rate, thus providing comparable heart rates before and after therapy. The increase of dP/dt and dP/dt/DP40 were also probably not due to changes of afterload, for systolic pressure was nearly constant, or to changes of preload, for the observed reduction of left ventricular In patients with normal filling pressure and normal contractility indexes, Hutton et al.6 observed an increase of peak positive dP/dt of 33% with a prenalterol dose of about 1.4 mg. In our patients, peak positive dP/ dt increased 38% with an almost 10-fold dose (12 mg) of prenalterol. In patients with COCM, who had lower baseline peak positive dP/dt, the increase in peak dP/dt induced by prenalterol was smaller than that in patients with IHD, though left ventricular filling pressure was equal. Similar results were obtained for dP/dt/DP40, ventricular power and work. This suggests that improvement of left ventricular contractility by prenalterol depends on baseline function. These results are confirmed by experimental studies of Newman and Webb,30 who found a reduced response to isoproterenol in dogs with artificial heart failure. Zucker ly, thereby improving stroke volume and ejection fraction. The percent changes for patients with IHD and COCM were similar. Left venitricular relaxation was reduced in IHD and COCM, as described by others.4""' The derangement was greater in COCM than IHD, as observed for con tractility. Prenalterol improved left ventricular relaxation as a typical catecholamine effect.45 46 Again, for peak negative dP/dt, the response in COCM was smaller than in IHD. The time constant T, describing a later period of left ventricular relaxation phase, was shortened to a greater extent in COCM than in IHD. This means that prenalterol can induce a marked and significant enhancement of relaxation even in patients in whom left ventricular contractility could be improved only slightly. Left ventricular comEpliance was significantly reduced in our patients with IHD and COCM, as in others reported.', 92 4r The effect of prenalterol on left ventricular compliance was dependent on the baseline values. In all patients with a slope av of more than 10 x 10-: ml-', an improved compliance was found. The observed effects were greater than those measured after adminiistration of nitroglycerin, atenolol or contrast material.'
The improved left ventricular relaxation and compliance would contribute greatly to the significant reduction of left ventricular filling pressure, as also reported previously.
The absolute and relative reductions in filling pressure were similar in IHD and COCM. TFhe decrease of left ventricular filling pressure is an acknowledged effect of symnpathlomimetic amines," but this effect seems to be dependent on resting filling pressure: Hutton and illustrated by pressure-volume curves the increase of end-diastolic volume after infusion of isoproterenol. Our four patients were characterized by very high enddiastolic pressures and impaired ventricular relaxation. In these patients, prenalterol may have caused a decrease in myocardial diastolic tone, and thereby left ventricular enlargement.
The principal determinants of myocardial oxygen consumption are heart rate, wall stress and inotropic state of the myocardium.49 Prenalterol increased heart rate, inotropic state and power, but wall stress tended to decrease. The transmyocardial gradient on which myocardial perfusion depends increased, because diastolic aortic pressure changed only slightly and left ventricular diastolic pressure decreased significantly. . Pressure-volume diagrams of six patients with congestive cardiomyopathy before (control) and after prenalterol infusion. In three of the six patients, end-diastolic and end-systolic volumes increased. In all patients, the diagramn is shifted downward and the area of the loop is increased by prenalterol.
Control Prenalterol FIGURE 5 . Left ventricular and aortic pressure wave forms before (control) and after prenalterol in a typical subject. The aortic pressure r-emained almost constant and ventricular diastolic pressure decreased markedly. Thus, the diastolic area between aortic and ventricular pressure increased, signifying an increased transmyocardial pressure gradient. In particular, the decrease of the elevated diastolic ventricular pressure would improve subendocardial blood flow. Therefore, we suggest that the increased oxygen demand of the myocardium34 is counterbalanced by an improved oxygen supply. The net effect seems to be positive. This situation is comparable to the decrease of myocardial oxygen consumption when cardiac glycosides are used in cardiac failure. 50 No angina pectoris was precipitated and ectopic depolarizations were seen only in one patient. Ventricular ectopic depolarizations are well-known side effects of other sympathomimetic amines such as dopamine and dobutamine.3 Long-term treatment of patients with severe heart failure is being undertaken to establish whether the subjective and objective improvement found with prenalterol is sustained or if tachyphylaxis will develop, as it does in other instances of chronic sympathomimetic amine use. 26 
